Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Weisman Harlan F | TX | DO | P,CEO | 2 | P | 282 | 0.3758 | 0 | 750 | 999% | 815 | D | ||||||||||||||
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Rocamboli Stephen | TX | D | 2 | P | 15 | 0.4677 | 0 | 33 | 999% | 36 | D | |||||||||||||||
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Roberts Brandi | TX | D | 1 | P | 5 | 0.2500 | 0 | 20 | 20 | D | ||||||||||||||||
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Coleman Kirk Allen | TX | O | CFO | 2 | P | 14 | 0.4518 | 0 | 32 | 871 | 36 | D | ||||||||||||||
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Mills Robert S | TX | D | 1 | P | 10 | 0.2500 | 0 | 40 | 250 | 56 | D | |||||||||||||||
8/15/23 08:00 | 8/15/23 | TFFP | Health | Drug | Pharmaceutical Preparations | Mikhak Zamaneh | TX | O | Chief Me | 2 | P | 42 | 0.3133 | 0 | 135 | 135 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |